BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22825855)

  • 1. KIT proto-oncogene exon 8 deletions at codon 419 are highly frequent in acute myeloid leukaemia with inv(16) in Indian population.
    Hussain SR; Naqvi H; Mahdi F; Bansal C; Babu SG
    Mol Biotechnol; 2013 Jun; 54(2):461-8. PubMed ID: 22825855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia.
    Gari M; Goodeve A; Wilson G; Winship P; Langabeer S; Linch D; Vandenberghe E; Peake I; Reilly J
    Br J Haematol; 1999 Jun; 105(4):894-900. PubMed ID: 10554798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core binding factor acute myeloid leukaemia and c-KIT mutations.
    Riera L; Marmont F; Toppino D; Frairia C; Sismondi F; Audisio E; Di Bello C; D'Ardia S; Di Celle PF; Messa E; Inghirami G; Vitolo U; Pich A
    Oncol Rep; 2013 May; 29(5):1867-72. PubMed ID: 23467883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of C-kit gene Mutation in Acute Myeloid Leukaemia in Northern India.
    Hussain SR; Raza ST; Babu SG; Singh P; Naqvi H; Mahdi F
    Iran J Cancer Prev; 2012; 5(1):27-32. PubMed ID: 25780536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of WT1 and KIT mutations in patients from an Indian population with de novo acute myeloid leukemia: determination of incidence, distribution patterns, and report of a novel KIT mutation.
    Ahmad F; D'Souza W; Mandava S; Das BR
    Leuk Lymphoma; 2011 May; 52(5):865-76. PubMed ID: 21504297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia.
    Tan Y; Liu Z; Wang W; Zhu G; Guo J; Chen X; Zheng C; Xu Z; Chang J; Ren F; Wang H
    Leuk Res; 2018 Jun; 69():89-93. PubMed ID: 29705537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).
    Boissel N; Leroy H; Brethon B; Philippe N; de Botton S; Auvrignon A; Raffoux E; Leblanc T; Thomas X; Hermine O; Quesnel B; Baruchel A; Leverger G; Dombret H; Preudhomme C; ;
    Leukemia; 2006 Jun; 20(6):965-70. PubMed ID: 16598313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.
    Qin YZ; Zhu HH; Jiang Q; Jiang H; Zhang LP; Xu LP; Wang Y; Liu YR; Lai YY; Shi HX; Jiang B; Huang XJ
    Leuk Res; 2014 Dec; 38(12):1435-40. PubMed ID: 25449688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].
    Qiao M; Li WY; Sun AN; Chen SN; Liang JY; Ding ZX; Feng YF; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):679-83. PubMed ID: 22339826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes.
    Zaker F; Mohammadzadeh M; Mohammadi M
    Arch Iran Med; 2010 Jan; 13(1):21-5. PubMed ID: 20039765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
    Pollard JA; Alonzo TA; Gerbing RB; Ho PA; Zeng R; Ravindranath Y; Dahl G; Lacayo NJ; Becton D; Chang M; Weinstein HJ; Hirsch B; Raimondi SC; Heerema NA; Woods WG; Lange BJ; Hurwitz C; Arceci RJ; Radich JP; Bernstein ID; Heinrich MC; Meshinchi S
    Blood; 2010 Mar; 115(12):2372-9. PubMed ID: 20056794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.
    Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC
    Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.
    Care RS; Valk PJ; Goodeve AC; Abu-Duhier FM; Geertsma-Kleinekoort WM; Wilson GA; Gari MA; Peake IR; Löwenberg B; Reilly JT
    Br J Haematol; 2003 Jun; 121(5):775-7. PubMed ID: 12780793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
    Sritana N; Auewarakul CU
    Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.
    Schnittger S; Kohl TM; Haferlach T; Kern W; Hiddemann W; Spiekermann K; Schoch C
    Blood; 2006 Mar; 107(5):1791-9. PubMed ID: 16254134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs)].
    He HY; Xiang YN; Li Y; Zhong HH; Wu BQ; Zheng J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):320-4. PubMed ID: 15968329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scanning of c-kit gene mutations in acute myeloid leukemias using high-resolution melting analysis].
    Yao DM; Qian J; Lin J; Chen Q; Xiao GF; Wang YL; Qian Z; Ji RB; Li Y; Yang J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):21-4. PubMed ID: 21429396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations and protein expression of KIT and PDGFRA genes in ipsilateral testicular seminomas: an immunohistochemical and molecular genetic study.
    Terada T
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):450-3. PubMed ID: 21403518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.